Cancer Res Treat.  2001 Jun;33(3):269-273.

A Case of Primary MALT Lymphoma of the Breast

Affiliations
  • 1Department of Internal Medicine, Fatima Hospital.
  • 2Department of Pathology, Fatima Hospital.
  • 3Seoul Breast Clinic.
  • 4Department of Pathology, Yeungnam University School of Medicine, Daegu, Korea.

Abstract

Primary malignant lymphoma of the breast is rare. The incidence of primary malignant lymphomas of the breast is 0.04% to 0.5% of all malignant tumors of the breast and 0.07% of all non-Hodgkin's lymphomas, and comprises 1.7% of extranodal malignant lymphomas that occur in Western countries. The incidence of mucosa- associated lymphoid tissue (MALT) lymphoma of the breast is reported to be between 0% and 75% of all primary malignant breast lymphomas in United States and Japan, but the incidence in Korea is unknown. MALT is characterized by indolent behavior and good has a prognosis. The authors report on a patient who has a primary MALT lymphoma of the breast. She was treated by surgical excision, which was followed by radiation therapy. Histologically, her lymphoma type transformed into a diffuse large B-cell tumor after 10months. She received combination chemotherapy and achieved a complete state of remission. She then underwent autologous peripheral blood stem cell transplantation along with high dose chemotherapy. To our knowledge, this is the first case report in the literature in Korea.

Keyword

Breast; MALT lymphoma

MeSH Terms

B-Lymphocytes
Breast*
Drug Therapy
Drug Therapy, Combination
Humans
Incidence
Japan
Korea
Lymphoid Tissue
Lymphoma
Lymphoma, B-Cell, Marginal Zone*
Lymphoma, Non-Hodgkin
Peripheral Blood Stem Cell Transplantation
Prognosis
United States
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr